|
Individuals with rheumatoid arthritis are being sought for a clinical trial at the IU School of Medicine. To be eligible, individuals must be between the ages of 18 and 75 years and have been diagnosed with the illness for at least six months. Participants must have active moderate to severe rheumatoid arthritis and currently taking methotrexate. The study will look at the effectiveness of an investigational drug. Participants will be involved in the study for approximately four months and will need to make about eight visits to the IU Medical Center campus in Indianapolis.
Rheumatoid arthritis affects 2.1 million Americans, primarily women. Onset usually is in middle age, but the disease can strike children and young adults. Research has shown that patients with rheumatoid arthritis who receive an early diagnosis and begin aggressive treatment are more likely to improve their quality of life while reducing disease activity and deformity. For additional information or to enroll in the trial, call 317-278-3166
|
